Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-12

FDA Approved: ABACAVIR — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for abacavir from Cipla USA Inc., representing an approved supplement to an existing abacavir product (e.g., labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

SUPPL AP for ABACAVIR (ABACAVIR)